Procaps Group S.A. (NASDAQ:PROC) Short Interest Update

Procaps Group S.A. (NASDAQ:PROC) was the target of a significant decline in short interest in December. As of December 15th, there was short interest totalling 163,300 shares, a decline of 21.7% from the November 30th total of 208,500 shares. Based on an average trading volume of 96,000 shares, the days-to-cover ratio is presently 1.7 days. Currently, 0.2% of the company’s stock are sold short.

Procaps Group Price Performance

PROC traded down $0.07 on Monday, reaching $2.28. The company’s stock had a trading volume of 24,749 shares, compared to its average volume of 35,466. Procaps Group has a 1 year low of $0.50 and a 1 year high of $4.95. The business’s 50 day moving average is $1.82 and its 200 day moving average is $2.06. The stock has a market cap of $257.23 million, a price-to-earnings ratio of 4.38 and a beta of 0.10.

About Procaps Group

Procaps Group SA develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory.